Background: L-Glutamate (Glu) is a major amino acid in milk and postweaning diets for mammals (including pigs and
Introduction
L-Glutamate (Glu) 5 is an abundant amino acid in milk and postweaning diets for mammals (including pigs and human infants) and in the intestinal mucosa (1) . Enteral Glu is a nutritionally and physiologically important precursor for the synthesis of bioactive molecules, such as polyamines (2) , glutathione (3), and amino acids [e.g., L-proline (4) , L-aspartate (5) and L-citrulline (6) ] in porcine and human enterocytes. Polyamines are essential for DNA and protein synthesis, thereby promoting proliferation and migration of intestinal epithelial cells along the crypt-villus axis (7) . Glutathione is required for regulating cell redox state and detoxification in all cell types (8) . Furthermore, studies in rats and pigs indicate that Glu is a major metabolic fuel for enterocytes and that ;96% of enteral Glu is metabolized in the small intestine during the first pass (9) (10) (11) (12) (13) . Furthermore, Glu can activate chemical sensors in the gastrointestinal tract, leading to the generation of serotonin (a neurotransmitter) by enteroendocrine cells (14) . Emerging evidence also shows that Glu plays important roles in intestinal nutrition (15) , cell signaling, the modulation of gene expression (16) , anti-inflammatory responses (17, 18) , and immunity (19, 20) . Transport of Glu primarily by the excitatory amino acid transporter 3 (EAAT3) is the first step in the utilization of this amino acid by enterocytes (21, 22) .
Tight junction between intestinal epithelial cells is the major portion of intestinal barrier that prevents the passage of bacteria from the intestinal lumen into blood circulation (23) . This mucosal barrier function is impaired under conditions of oxidative stress brought about by excess reactive oxygen species (24) . Diquat is widely used as an oxidant in in vitro or in vivo experiments to induce oxidative stress and apoptosis (25, 26) . Glutamate supplementation ameliorates endotoxin-induced damage to the jejunal epithelium and intestinal paracellular hyperpermeability (27, 28) , suggesting a critical role for Glu in intestinal-mucosal barrier function.
Although Glu is known to be essential for maintaining intestinal mucosa integrity and antioxidative responses (29) , the underlying cellular and molecular mechanisms remain largely unknown. We hypothesized that Glu can maintain intestinal barrier function in diquat-challenged enterocytes by upregulating expression of tight junction protein. This hypothesis was tested in the present study with the use of intestinal porcine epithelial cell line 1 (IPEC-1) cells, which metabolize Glu in a way similar to that of enterocytes freshly isolated from neonatal pigs (30) .
Methods
Reagents. DMEM F12 Ham medium, FBS, PBS, and Typsin/EDTA were procured from GIBCO. Epidermal growth factor and insulin-transferrinselenium were obtained from BD Biosciences. Plastic culture plates were manufactured by Corning. Unless indicated, all other chemicals were purchased from Sigma-Aldrich.
Cell culture. The IPEC-1 cells were cultured as previously described (31) . Cells were cultured with serum-and Glu-free custom-made DMEM (modified DMEM no. 08-5009EF, GIBCO). The basal medium contained 5 mmol/L D-glucose, no Glu, and physiologic concentrations of all other amino acids (including 0.5 mmol/L L-glutamine) found in the plasma of neonatal pigs (31) . The medium was supplemented with 5% FBS and 5 mg/mL insulin in diquat-free experiments. Cells were treated with 0-, 0.5-, 1-, or 2 mmol/L Glu for 24 or 48 h. These concentrations of Glu were chosen on the basis of those in the jejunal lumen (jejunal luminal fluid samples) of neonatal pigs, which were 0.029 6 0.006, 0.48 6 0.04, 1.03 6 0.07, and 2.15 6 0.18 mmol/L (mean 6 SEM, n = 6), respectively, in newborn unsuckled pigs, and 6-, 12-, and 24-h-old suckling piglets Step PCR Kit (AMV) (TaKaRa) according to the manufacturerÔs instructions. b-Actin was used as the endogenous control. All data were expressed as the values relative to those for the 0 mmol/L Glu group. The primers used for solute carrier family 1 member 1 (SLC1A1) and b-actin were as follows: SLC1A1, 5#-GGCACCGCACTCTACGAAGCA-3# and 5#-GCCCACGGCACTTAGCACGA-3#; b-actin, 5#-TCTGGCAC-CACACCTTCTACA-3# and 5#-ATCTGGGTCATCTTCTCACGG-3, respectively.
Determination of cell membrane integrity. Lactate dehydrogenase (LDH) in IPEC-1 cell culture medium was determined as previously reported (32) . Briefly, cells were cultured with or without Glu as indicated in the presence or absence of 1 mmol/L diquat for 6 h. Thereafter, the medium was collected and LDH activity was measured with the use of an ultraviolet-visible spectrophotometer (450 nm) and a kit from Jiancheng Bioengineering. All data are expressed as the values relative to those for the 0 mmol/L Glu group.
Western blot analysis. Cells were incubated with or without Glu in the presence or absence of diquat for indicated time points. Cells were then harvested for analysis of abundance of proteins through the use of Western blotting as previously described (33) Statistical analysis. Results are expressed as means 6 SEMs. Data were analyzed by 1-factor ANOVA with the use of SAS, version 9.0. The Student-Newman-Keuls multiple comparison test was applied to determine differences between treatment means. P < 0.05 was taken to indicate statistical significance. Glutamate inhibited diquat-induced cellular damage. Cell numbers were lower (P < 0.05) in the diquat-treated group than in the 0 mmol/L Glu group ( Figure 4A ). In the presence of diquat, the numbers of cells pretreated with 0.5-and 1 mmol/L Glu were higher than those pretreated with 0 mmol/L Glu (P < 0.05), indicating a beneficial effect from Glu on attenuating a diquat-induced reduction in cell numbers. Consistent with these results, diquat-challenged cells exhibited an increase (P < 0.05) in LDH release into the culture medium in the absence of Glu compared with cells without exposure to diquat ( Figure 4B) . However, the amount of LDH in the medium of diquat-treated IPEC-1 cells cultured with 0.5-and 1 mmol/L Glu was lower (P < 0.05) than those for cells cultured with 0 mmol/L Glu. Interestingly, LDH activity in the culture medium did not differ between the 0 and 1 mmol/L Glu groups. After IPEC-1 cells were cultured in the presence of diquat for 6 h, TEER was measured continuously for 8 h. In response to diquat, TEER exhibited a marked decrease (P < 0.05) in a time-dependent manner in the 0 mmol/L Glu group compared with the 0.5 mmol/L Glu group ( Figure 5) . In contrast, the diquat-induced TEER reduction was attenuated (P < 0.05) by pretreatment with 0.5 mmol/L Glu at both 4 h and 6 h.
Results

Effects of Glu
Effects of
. The abundance of tight junction proteins in IPEC-1 cells was determined. Compared with control, diquat treatment led to decreased (P < 0.05) protein abundance of claudin-1, claudin-3, claudin-4, (Figure 6 ), ZO-1, ZO-2, and ZO-3 ( Figure 7 ) in the absence of Glu. In the presence of diquat, cells cultured with 0.5 and 1 mmol/L Glu exhibited higher protein abundance of claudin-3, claudin-4, ZO-2, and ZO-3 compared with the 0 mmol/L Glu group (P < 0.05). In contrast, diquat treatment resulted in decreased (P < 0.05) protein abundance of claudin-1 and ZO-1 (Figures 6 and 7) , regardless of Glu addition. In the absence of Glu, diquat exposure led to enhanced protein abundance of occludin (P < 0.05), which was not affected by Glu supplementation (Figure 6 ).
Discussion
Glu in the enteral diet is almost completely catabolized by the small intestine in the first pass, and only 5% of enteral glutamate enters the portal circulation in young pigs (11, 13) . Enterocytes are major cell types for intestinal utilization of Glu in mammals, including pigs (9, 11, 12) . Of note, as a building block of protein, Glu is required for the proliferation and differentiation of these (34) . Many factors, such as weaning, illness, and toxins, can reduce the intestinal mucosal barrier function and, therefore, cause infection and growth depression in animals (35) . We and others have reported that dietary supplementation with Glu enhances intestinal villus height, mucosal glutathione concentration, antioxidative capacity, and growth in early-weaned piglets (15, 36) . However, the mechanisms responsible for the beneficial effects of Glu are largely unknown. Using the diquattreated IPEC-1 cell model, we determined effects of physiologic concentrations of Glu on expression of tight junction protein concentrations, as well as cell membrane integrity and TEER. Our novel findings are expected to provide a hitherto unrecognized biochemical basis for dietary supplementation with Glu as a functional amino acid (19) to improve intestinal health and growth in neonatal mammals, including piglets and human infants.
Glutamate displays metabolic versatility in the small intestine (37) . For example, Glu increases the expression of proliferating cell nuclear antigen in the jejunum of weanling piglets (38) . In enterocytes, Glu undergoes transamination with oxaloacetate and pyruvate to produce L-aspartate and L-alanine (5), respectively. The carbon skeleton of Glu is oxidized to produce ATP in enterocytes via the mitochondrial tricarboxylic acid cycle (39) . Furthermore, through the formation of N-acetylglutamate (an allosteric activator of carbamylphosphate synthetase-I) and L-aspartate (a substrate for argininosuccinate synthase), Glu stimulates the intestinal synthesis of citrulline and arginine (40) . These Glu-dependent biochemical reactions may explain our finding that Glu enhanced the proliferation of IPEC-1 cells regardless of the presence or absence of diquat ( Figure 2 ).
As noted previously, the intestinal epithelium is a physical structure separating the internal from the external environment in animals (34) while allowing for rapid uptake of water, electrolytes, and other nutrients from the intestinal lumen into the circulation (41) . The intestinal barrier function is supported by the intestinal epithelial cell membrane and tight junction between the cells (34) . Intracellular or extracellular stress leads to impaired mucosal barrier function and increased release of LDH from cells (as indicated by the amount of LDH in the culture medium) (32) . In our study, we found that diquat induced oxidative stress in IPEC-1 cells and augmented LDH release from these cells. Of note, the addition of Glu to the culture medium markedly decreased LDH release from diquat-treated cells. These results indicate a novel and important role for Glu in maintaining the integrity of the IPEC-1 cell membrane.
Another indicator of enterocyte integrity is TEER, which refers to the permeability of intestinal epithelium. High TEER means low intercellular permeability of the epithelium. Some factors, such as inflammation, stress and injury, result in increased permeability of the intestinal epithelium, leading to dysfunction of intestinal mucosal barrier (42) . Studies have shown that treatment with some probiotic bacteria may prevent or reverse the increase of permeability of the intestinal epithelium (43, 44) . We showed that the presence of Glu in culture medium led to increased TEER regardless of oxidative stress in intestinal epithelial cells (Figures 2 and 5) , suggesting a beneficial role for Glu in maintaining mucosal barrier function in animals. It should be noted that Glu is a major metabolite of the normal intestinal bacterial metabolism (17) that plays an important role in reducing the intercellular permeability of the intestinal epithelium. Thus, Glu may mediate in part the action of probiotics on enterocytes, suggesting close relations between amino acids, gut microbes, and the host.
As the first step in identifying mechanisms for Glu to ameliorate diquat-induced oxidative stress and apoptosis in IPEC-1 cells, we determined the expression of EAAT3, which is the major transporter for transporting Glu into the enterocyte. Loss of function mutations in SLC1A1 causes dicarboxylic aminoaciduria in humans (45) . In agreement with a previous study (46) , we observed that both mRNA and protein abundances of EAAT3 (encoded by SLC1A1) were enhanced by Glu, which might facilitate Glu absorption and exert beneficial effects on increases rapidly from 0.16 to 1.05 mmol/L between day 0 and day 7 of lactation (47) .
The intercellular junctional complex between enterocytes is critical for the integrity of the intestinal mucosal barrier, which consists of tight junctions, adheren junctions, gap junctions, and desmosomes (48, 49) . Tight junctions that limit paracellular flux are the apical intercellular junction (50, 51) . The tight junction proteins, including occludin, claudins, and ZO, provide a functional structure in the small-intestinal epithelium. Expression of these proteins is regulated by various stimuli, such as mitogenactivated protein kinases, protein kinase C, and certain amino acids, including tryptophan (33, 52, 53) . Although the beneficial effect of Glu on intestinal health has been studied (53, 54) , a role for Glu in regulating the expression and amounts of tight junction proteins has not been reported. Glutamate augments the abundance of these proteins possibly by stimulating their synthesis at the transcriptional level and inhibiting their degradation. At present, little is known about the effects of Glu on proteolysis in enterocytes via the lysosomal pathway (e.g., autophagy) or the nonlysosomal pathway (e.g., ATP-and ubiquitin-dependent protease). Nonetheless, our results have important implications for neonatal gut nutrition. Specifically, Glu deprivation may lead to decreased expression of tight junction proteins, thereby impairing intestinal mucosal barrier function. Because the small intestine does not take up arterial Glu (4), enteral provision of this amino acid is crucial for the growth, development, and function of the neonatal gut. Thus, newborn piglets, whose smallintestinal lumen has little Glu (i.e., 0.03 mmol/L) at birth (12) , must receive enteral provision of adequate Glu in the form of either milk or Glu-containing infant formula to ensure healthy growth and development of the gut, particularly under conditions of oxidative stress.
In summary, the addition of physiologic concentrations of Glu to culture medium enhances proliferation and membrane integrity of IPEC-1 cells. These effects of Glu are mediated by increased expression of tight junction proteins in the cells. Furthermore, Glu has a protective effect on diquat-induced oxidative stress in IPEC-1 cells. Collectively, these results provide a new biochemical basis for the beneficial role of Glu in promoting intestinal growth, development, and health. Our findings have important implications for nutritional support of neonatal mammals, including piglets and human infants.
